Formulary Coverage for Lipid-Lowering Drugs Recommended for Children
Yoon EY et al. - If new recommendations of the American Academy of Pediatrics for treatment of dyslipidemia in children were implemented today, children with the public plan would have equal choice but better coverage of lipid-lowering drugs as preferred drugs, including those with FDA approval, compared with children with the private plan. [more...]
|
|
|
